Literature DB >> 10428145

Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.

P Acién1, F Quereda, P Matallín, E Villarroya, J A López-Fernández, M Acién, M Mauri, R Alfayate.   

Abstract

OBJECTIVE: To analyze the correlations among insulin, androgens, body mass index (BMI), and other related metabolic anomalies in women with and without polycystic ovary syndrome (PCOS).
DESIGN: Retrospective study of normal and obese women with and without PCOS.
SETTING: Gynecologic endocrinology units of Elche, San Juan, and Alicante Hospitals and Hormone Laboratory at Alicante University Hospital ("Miguel Hernández" University). PATIENT(S): A total of 212 women were studied: 137 with PCOS and 75 without PCOS. INTERVENTION(S): BMI, gonadotropins, insulin, androgens (T, androstenedione, DHEAS), 17alpha-hydroxyprogesterone, sex hormone-binding globulin, and triglycerides were studied. Glycemia and insulin response to the tolerance test (GTT) with a 100-g oral glucose load were also assessed in 103 women. RESULT(S): A good correlation between insulin and BMI was found in normal and obese women without hormonal dysfunction and in patients with or without PCOS. Good correlations, although lower, between insulin and T, and BMI, insulin, and T with triglycerides were also found in patients with PCOS. These patients fell into clearly distinct categories: with or without insulin resistance and with or without obesity, but slim women with PCOS had insulin and metabolic variables similar to those without PCOS, and most obese women with PCOS were insulin-resistant and more hyperandrogenic and hypertriglyceridemic. CONCLUSION(S): Insulin, androgens, and BMI are related in women both with PCOS and without PCOS, especially in obese ones. Insulin and metabolic indices are similar in lean women with PCOS and those without PCOS, but obese women with PCOS are more insulin-resistant, hyperandrogenic, and hypertriglyceridemic. Three types of disorders can be distinguished: simple nonhyperandrogenic obesity, typical nonhyperinsulinemic PCOS, and insulin-resistant PCOS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428145     DOI: 10.1016/s0015-0282(99)00184-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  25 in total

1.  Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

Authors:  Tomoko Asagami; Tyson H Holmes; Gerald Reaven
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

2.  Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome.

Authors:  S Ajossa; S Guerriero; A M Paoletti; M Orrù; S Floris; M Mannias; G B Melis
Journal:  J Assist Reprod Genet       Date:  2001-08       Impact factor: 3.412

3.  Interleukin 1 beta (IL-1β) promoter C [-511] T polymorphism but not C [+3953] T polymorphism is associated with polycystic ovary syndrome.

Authors:  Yuan Mu; Jingjing Liu; Binbin Wang; Qiaolian Wen; Jing Wang; Jinting Yan; Sirui Zhou; Xu Ma; Yunxia Cao
Journal:  Endocrine       Date:  2009-11-10       Impact factor: 3.633

4.  Assessing and treating insulin resistance in women with polycystic ovarian syndrome.

Authors:  Michael L Traub
Journal:  World J Diabetes       Date:  2011-03-15

5.  Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep.

Authors:  A Veiga-Lopez; J Moeller; D Patel; W Ye; A Pease; J Kinns; V Padmanabhan
Journal:  Endocrinology       Date:  2013-03-24       Impact factor: 4.736

6.  Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.

Authors:  Anindya Dasgupta; Aparna Khan; Ushasi Banerjee; Mrinalkanti Ghosh; Mrinal Pal; Kanika M Chowdhury; Sayantan Dasgupta
Journal:  Indian J Clin Biochem       Date:  2012-09-14

7.  Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome.

Authors:  Ban H Khalaf
Journal:  Saudi Pharm J       Date:  2009-12-23       Impact factor: 4.330

8.  Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese.

Authors:  Binbin Wang; Jing Wang; Jingjing Liu; Feng Ni; Jinting Yan; Sirui Zhou; Yuan Mu; Yunxia Cao; Xu Ma
Journal:  Endocrine       Date:  2009-06-09       Impact factor: 3.633

9.  Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

Authors:  W K McGee; C V Bishop; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

10.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.